HIND

Vyome Holdings, Inc.

Vyome Holdings, Inc. (HIND) is rated C+ (2.6/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Value (B-); its weakest is Profitability (C). The rating has held at C+ for 5 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
2.6 / 5.0
C+
Value
B-
Factor Score 3.1 / 5.0
Growth
C+
Factor Score 2.6 / 5.0
Profitability
C
Factor Score 2.2 / 5.0
Momentum
C
Factor Score 2.3 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio 0.9
EV / EBITDA -1.0
Rev Growth YoY -46.0%
Gross Margin 52.7%
Price Return 3M -27.3%
Price Return 12M -71.1%
Catalyst Signal 0.00
Market Cap $11.0M
TTM Revenue $129.7K
Price / Sales 84.9
ROE N/M

Historical Factor Score Progression

Held C+ for 5 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-11-12 B- (3.1) C+ (2.6) C (2.2) C (2.3) C+ (2.6) C+ (2.6)
2026-11-05 B- (3.1) C+ (2.5) C (2.2) C (2.3) C+ (2.7) C+ (2.6)
2026-10-29 B- (3.1) C+ (2.6) C (2.3) C (2.3) C+ (2.7) C+ (2.6)
2026-10-22 B- (3.1) C+ (2.6) C (2.3) C- (2.0) C+ (2.6) C+ (2.5)
2026-10-15 B- (3.0) C+ (2.6) C (2.3) C (2.2) C+ (2.6) C+ (2.5)
Page 1 of 4